MASS (908 Devices) Risk Assessment


MASS 908 Devices Inc MASS
70 GF Score
Price $8.40
GF Value $6.96
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is 908 Devices Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of 908 Devices is: High Risk: High uncertainty with risk-return tradeoff.

908 Devices  (NAS:MASS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

908 Devices Risk Assessment Related Terms

MASS vs ELMD, CATX, SGHT: Risk Assessment Comparison

For the Medical Devices subindustry, 908 Devices's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

908 Devices Risk Assessment vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, 908 Devices's Risk Assessment distribution charts can be found below:

* The bar in red indicates where 908 Devices's Risk Assessment falls into.


MASS
70GF Score
908 Devices Inc MASS
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is 908 Devices (MASS) Overvalued in 2026?

Based on GuruFocus' analysis, 908 Devices stock appears to be overvalued. The current stock price of $8.40 is trading 20.7% above its estimated GF Value™ of $6.96. GuruFocus considers 908 Devices to be Modestly Overvalued.

Key valuation signals for MASS:

  • Risk Assessment:
  • GF Value™: $6.96 vs. price of $8.40 (20.7% above fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the MASS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

908 Devices Business Description

Address 44 3rd Avenue, Burlington, MA, USA, 01803
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
70GF Score

Get the complete analysis for MASS

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.40
Price
$6.96
GF Value